An Open-label, Fixed-sequence Study in Healthy Study Participants to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2018
Price : $35 *
At a glance
- Drugs Padsevonil (Primary) ; Erythromycin
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB Biopharma
- 06 Sep 2018 Status changed from active, no longer recruiting to completed.
- 02 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Apr 2018 Status changed from not yet recruiting to recruiting.